Clinical implications of hepatic steatosis in patients with chronic hepatitis C: A multicenter study of U.S. veterans

Ke Qin Hu, Sue L. Currie, Hui Shen, Ramsey C. Cheung, Samuel B. Ho, Edmund J. Bini, John D. McCracken, Tim Morgan, Norbert Bräu, Warren N. Schmidt, Lennox Jeffers, Teresa L. Wright

Research output: Contribution to journalArticlepeer-review

26 Scopus citations

Abstract

Studies have indicated a high prevalence of hepatic steatosis in patients with chronic hepatitis C (CHC). To address the impact of steatosis on the clinical course of CHC and treatment response requires large multicenter studies. The present study analyzed hepatitis C virus (HCV)-infected veterans enrolled in a U.S. Veteran Administration multicenter study of the epidemiology and response to interferon α-2b and ribavirin treatment. Of the 357 patients, 97.1% were males, with a mean age of 48.7±6.4 years, and 184 (51.5%) had hepatic steatosis. The mean body mass index (BMI) was 29.3±5.2 kg/m2, including 37.1% who were obese (BMI, ≥30 kg/m2). Stage III-IV fibrosis was present in 111 of 334 (33.3%) of the patients. After adjusting for age, race, and history of alcohol use in the past 12 months, only stage III-IV fibrosis was independently and significantly associated with hepatic steatosis (P=0.03). There was a trend of association between obesity and steatosis independent of the other factors. Only HCV genotype was independently associated with a sustained virological response (SVR) to interferon α-2b and ribavirin treatment after adjusting for age, alcohol use, steatosis, BMI, stage III-IV fibrosis, serum AFP, and HCV load. In conclusion, analyses of our multicenter trial data demonstrated that the prevalence of hepatic steatosis is 51.5% in HCV-infected U.S. veterans. We found that steatosis is independently associated with stage III-IV fibrosis. However, only HCV genotype, and not steatosis, obesity, or stage III-IV fibrosis, was associated with SVR to interferon α-2b and ribavirin treatment.

Original languageEnglish (US)
Pages (from-to)570-578
Number of pages9
JournalDigestive Diseases and Sciences
Volume52
Issue number2
DOIs
StatePublished - Feb 2007

Keywords

  • Body mass index
  • Chronic hepatitis C
  • Hepatic fibrosis
  • Hepatic steatosis
  • Hepatitis C virus
  • Obesity

ASJC Scopus subject areas

  • Gastroenterology

Fingerprint Dive into the research topics of 'Clinical implications of hepatic steatosis in patients with chronic hepatitis C: A multicenter study of U.S. veterans'. Together they form a unique fingerprint.

Cite this